RE:If MF had waited till tomorrow I agree with you. I've said on here a few times that every day that passes reduces the value bucillamine might have. It's like, "hey, I have a treatment for polio." That's good, but most people are covered via a vaccine.
I think the more troubling question is does this company and management have the ability to put things over the finish line? Execution matters. Being quick does matter. Even as a shroom play, It's a crowded sector. Why should investors believe in them? This has a halo effect in my view.
Just my opinion.